AgreeI have said for years , that in my opinion if they had hired a seasoned high level person from BP who had successfully gotten drugs approved through various RAs , had connections , and launched them succefully, it would have been much better hire than Black:
With all those tall tails the gang has managed to net ~50,000 investors with no institutional to speak of. I find it very hard to believe that they’re looking out for retail and intend to provide them with a windfall? It’d probably be a first.
I am convinced that misteps have cost us ROI and unfortunately many lives.
Unless they have a major partnership lined up post approval who will then grab the reigns and ensure this gets to market asap, I see a future of continued missteps. I fear the partnerships will be with other Toucan investments and we will continue with this go it alone strategy. I want to unload my initial investment when it gets to $5 and then be done with watching this train wreck. Dreams of a short squeeze and outlandish market cap valuations are long gone.